Prevention remains the strongest defense against disease
In the Philippines, where an estimated 220,000 people live with HIV and women among them face a sixfold elevated risk of cervical cancer, a pharmaceutical company has stepped into a long-standing gap in preventive care. MSD Philippines donated 1,500 HPV vaccine doses to PHAPCares Foundation, enough to fully protect 500 people living with HIV who have largely been absent from the country's immunization conversations. The gesture is modest against the scale of need, yet it carries the weight of a principle: that prevention is only meaningful when it reaches those most endangered by its absence.
- Women living with HIV in the Philippines carry a sixfold greater risk of cervical cancer, yet HPV vaccination for this population has remained sparse despite clear WHO guidance.
- With roughly 220,000 Filipinos living with HIV and limited public health resources, the gap between international recommendations and on-the-ground reality has grown quietly urgent.
- MSD Philippines transferred 1,500 vaccine doses to PHAPCares Foundation, providing three-dose protection for 500 people living with HIV over a six-to-twelve-month window.
- Peer health workers like clinic case manager Harvey Alvarez underscore the difficulty of simply reaching people in HIV-affected communities, making integrated, accessible programs essential.
- The donation aligns with WHO's 90-70-90 cervical cancer elimination target for 2030, nudging the Philippines toward a model where HIV care and HPV prevention are no longer treated as separate concerns.
A pharmaceutical company in the Philippines has donated fifteen hundred HPV vaccine doses to a foundation serving people living with HIV, offering three-dose protection to five hundred individuals who face an outsized risk of vaccine-preventable cancers. The gift from MSD Philippines to PHAPCares Foundation, made through Project Red Ribbon, addresses a gap that has persisted quietly for years.
The vulnerability is well documented. Women living with HIV are six times more likely to develop cervical cancer than women without the virus, yet despite WHO recommendations urging HPV vaccination for immunocompromised populations, awareness and access for this group in the Philippines have remained thin. Of the estimated 220,000 Filipinos living with HIV, most have had little institutional support for HPV prevention.
MSD Philippines has spent more than a decade advancing HPV immunization through school-based programs and public campaigns, but those efforts have largely centered on younger populations in institutional settings—leaving adults navigating HIV largely outside the conversation. This donation represents a deliberate turn toward that overlooked group.
The initiative arrives as the WHO presses toward its 90-70-90 cervical cancer elimination strategy by 2030, which calls on countries to integrate HPV prevention with existing health services and prioritize at-risk populations. Harvey Alvarez, a clinic case manager and peer support coordinator at My Hub Cares, captured the practical stakes: reaching people in HIV-affected communities is itself a challenge, and programs that combine care with protection carry real meaning.
The donation will not close the full distance between need and coverage—the scale of vulnerability across the country remains far larger than any single contribution can resolve. But it signals a shift in how prevention is being imagined: not as a universal program that incidentally misses the most at-risk, but as something that must be built around them.
A pharmaceutical company in the Philippines has handed over fifteen hundred doses of HPV vaccine to a foundation that serves people living with HIV, a move designed to shield five hundred individuals from cancers that the virus can cause. The donation, made by MSD Philippines to the PHAPCares Foundation on behalf of Project Red Ribbon, represents a direct response to a gap in preventive care that has long gone unaddressed in the country.
The numbers tell part of the story. According to the Joint United Nations Programme on HIV and AIDS, roughly two hundred twenty thousand Filipinos are living with HIV. Among them, women face a particular vulnerability: those with HIV are six times more likely to develop cervical cancer than women without the virus. Yet despite international health guidelines—including recommendations from the World Health Organization—that call for HPV vaccination in people with compromised immune systems, awareness remains low and access to the vaccine for this population has been sparse. The vaccine requires three doses administered over six months to a year to provide full protection.
MSD Philippines has spent more than a decade working with government agencies and health partners to expand HPV immunization across the country. The company has supported school-based vaccination programs that ran annually through 2024, and backed public campaigns with names like "One Community Against Cervical Cancer" and "Tapusin Natin"—a reference to finishing the job of protection. But those efforts, while significant, have largely focused on younger populations in institutional settings. People living with HIV, many of them adults navigating complex health needs, have been largely absent from those conversations.
The timing of this donation aligns with a global health target. The World Health Organization has set a 90-70-90 strategy aimed at eliminating cervical cancer by 2030: ninety percent of girls fully vaccinated by age fifteen; seventy percent of women screened between thirty-five and forty-five; and ninety percent of women diagnosed with the disease receiving treatment. The Philippines, like many countries with limited public health resources, must make strategic choices about where to direct those resources. The WHO has explicitly urged countries to integrate HPV prevention with other health services and to prioritize at-risk groups—a category that clearly includes people living with HIV.
Harvey Alvarez, who works as a clinic case manager and peer support coordinator at My Hub Cares, spoke to the real-world challenge this addresses. In communities affected by HIV, he noted, simply reaching people can be difficult. Programs that allow individuals to access health care while also protecting younger generations matter deeply. The collaboration between MSD, PHAPCares—the social responsibility arm of the Pharmaceutical and Health Care Association of the Philippines—and Project Red Ribbon, which has long advocated for people living with HIV, represents an attempt to move beyond awareness into action.
What makes this donation significant is not just the number of doses or the people who will receive them, though those matter. It is the recognition that prevention works best when it reaches the people most at risk, and that those people have been overlooked. Women living with HIV in the Philippines have faced a sixfold increased risk of cervical cancer with little institutional support to change that equation. This donation, and the partnerships it represents, begins to shift that reality—though the scale of need across the country remains far larger than what any single donation can address.
Citações Notáveis
In our community, reaching out can be difficult. That's why we need programs like this, which allow us to express ourselves, access health care, and protect the younger generation.— Harvey Alvarez, clinic case manager and peer support at My Hub Cares
A Conversa do Hearth Outra perspectiva sobre a história
Why does a person living with HIV need an HPV vaccine at all? Isn't their immune system already compromised?
That's exactly the problem. Their immune system is weaker, which means they're more vulnerable to infections—including HPV—and to the cancers those infections can cause. The vaccine works by teaching the body to recognize and fight the virus before it causes damage. For people with HIV, that protection becomes even more critical.
But if their immune system is weak, will the vaccine even work?
That's a real question, and it's part of why this has been overlooked. The vaccine does work in people with HIV, especially if their immune system has been strengthened through antiretroviral treatment. But because the efficacy might be lower than in people without HIV, and because awareness has been so limited, many people living with HIV have never even been offered the option.
So this is about a gap in the system—people falling through the cracks.
Exactly. The Philippines has done school-based HPV vaccination for years, which is good. But that reaches teenagers in classrooms. Adults living with HIV? They're not in those programs. They're managing a chronic illness, often with limited access to preventive care. No one was thinking about them.
What changes now that these fifteen hundred doses are available?
Five hundred people get the chance to protect themselves from cancers they're at much higher risk of developing. But more than that, it signals that this population matters—that their health is worth investing in. It's a beginning, not a solution.
Is there a risk this becomes a one-time gesture?
That's the real question. The donation is meaningful, but the need is ongoing. What matters is whether this opens a conversation about integrating HPV prevention into regular HIV care, so it becomes routine rather than dependent on individual donations.